Literature DB >> 5774106

Formation of iodoprotein during the peripheral metabolism of 3,5,3'-triiodo-L-thyronine-125I in the euthyroid man and rat.

M I Surks, J H Oppenheimer.   

Abstract

3,5,3'-Triiodo-L-thyronine-(125)I (T3-(125)I) metabolism was studied in nine euthyroid human subjects on blocking doses of nonradioactive iodide. After the intravenous injection of T3-(125)I, the fractional disappearance rate of plasma radioactivity progressively disappearance rate of plasma radioactivity progressively decreased with time. Analysis of individual plasma samples by dialysis, electrophoretic, and extraction techniques revealed three radioactive components: T3-(125)I, iodide-(125)I, and an unidentified material which was nonextractable in acid butanol (NE(125)I). Ne(125)I rose to maximal levels 24-36 hr after injection of T3-(125)I and then decreased with a fractional rate which approached, after 12-14 days, approximately 0.05 day(-1) (t(1/2) = 14 days). The plasma T3-(125)I concentration, obtained by subtraction of iodide-(125)I and NE(125)I from the plasma total (125)I, declined at a constant fractional rate with time with a t(1/2) of 1.5 days. Qualitatively similar results were obtained in rats. After 72 hr, 57% of the plasma and 40% of the liver radioactivity was NE(125)I. Chromatographic purification of the T3-(125)I before injection did not alter these results. The extrathyroidal origin of NE(125)I was further demonstrated by similar results in thyroidectomized rats maintained on thyroxine. NE(125)I from human sera separated from the other radioiodinated substances by ion-exchange chromatography was quantitatively precipitated by trichloracetic acid, not dialyzable, insoluble in CHCl(3):CH(2)OH, and migrated with albumin during starch-gel electrophoresis. Based on these properties, NE(125)I was tentatively identified as iodoalbumin. Observations in rats equilibrated with (125)I, as well as nonradioactive iodine determinations in human sera before and after acid butanol extraction, indicate that 10-20% of the serum organic iodine is in the form of iodoprotein. Our studies suggest that this moiety may be derived at least in part from the peripheral metabolism of the thyroid hormones.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5774106      PMCID: PMC322273          DOI: 10.1172/JCI106026

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Some notes on the exchange of iodine with thyroxine homologues.

Authors:  G I GLEASON
Journal:  J Biol Chem       Date:  1955-04       Impact factor: 5.157

2.  Disappearance of I-131-triiodo-thyronine from the plasma in the presence of fever.

Authors:  J G WISWELL; V CORONHO
Journal:  J Clin Endocrinol Metab       Date:  1962-06       Impact factor: 5.958

3.  The mechanism of protein iodination during the metabolism of thyroid hormones by peripheral tissues.

Authors:  V A GALTON; S H INGBAR
Journal:  Endocrinology       Date:  1961-07       Impact factor: 4.736

4.  An iodine compound associated with albumin in the plasma of thyrotoxic patients.

Authors:  C CAMERON; K FLETCHER
Journal:  Nature       Date:  1959-01-10       Impact factor: 49.962

5.  Conjugates of triodothyronine and its metabolites.

Authors:  E V FLOCK; J L BOLLMAN; J H GRINDLAY
Journal:  Endocrinology       Date:  1960-09       Impact factor: 4.736

6.  Discrepancy between the distributions of iodine in human serum when estimated by iodine-131 and iodine-127.

Authors:  S C WERNER; R J BLOCK
Journal:  Nature       Date:  1959-02-07       Impact factor: 49.962

7.  The metabolism of triiodothyronine in Graves' disease.

Authors:  I B HALES; B M DOBYNS
Journal:  J Clin Endocrinol Metab       Date:  1960-01       Impact factor: 5.958

8.  Determination of iodine compounds in serum. I. Serum thyroxine in the presence of some iodine contaminants.

Authors:  V J PILEGGI; N D LEE; O J GOLUB; R J HENRY
Journal:  J Clin Endocrinol Metab       Date:  1961-10       Impact factor: 5.958

9.  Properties of a rat tissue iodothyronine deiodinase and its natural inhibitor.

Authors:  S Nakagawa; W R Ruegamer
Journal:  Biochemistry       Date:  1967-05       Impact factor: 3.162

10.  An analysis of published data on thyroxine turnover in human subjects.

Authors:  T H Oddie; J H Meade; D A Fisher
Journal:  J Clin Endocrinol Metab       Date:  1966-04       Impact factor: 5.958

View more
  16 in total

1.  Estimation of tetraiodothyroacetate in human serum.

Authors:  D B Ramsden; P J Raw; P J Carter; R Hoffenberg
Journal:  Proc R Soc Med       Date:  1975-02

2.  The interpretation of the serum protein-bound iodine: A review.

Authors:  J D Acland
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

3.  Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man.

Authors:  M Inada; K Kasagi; S Kurata; Y Kazama; H Takayama; K Torizuka; M Fukase; T Soma
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

4.  The extrathyroidal conversion rate of thyroxine to triiodothyronine in normal man.

Authors:  C S Pittman; J B Chambers; V H Read
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

5.  The distribution kinetics of triiodothyronine: studies of euthyroid subjects with decreased plasma thyroxine-binding globulin and patients with Graves' disease.

Authors:  R R Cavalieri; M Steinberg; G L Searle
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

6.  The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism.

Authors:  K A Woeber; R J Sobel; S H Ingbar; K Sterling
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

7.  Differences in primary cellular factors influencing the metabolism and distribution of 3,5,3'-L-triiodothyronine and L-thyroxine.

Authors:  J H Oppenheimer; H L Schwartz; H C Shapiro; G Bernstein; M I Surks
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

8.  Quantitation of extrathyroidal conversion of L-thyroxine to 3,5,3'-triiodo-L-thyronine in the rat.

Authors:  H L Schwartz; M I Surks; J H Oppenheimer
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

9.  Triiodothyronine radioimmunoassay.

Authors:  J Lieblich; R D Utiger
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

10.  Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

Authors:  J T Nicoloff; J C Low; J H Dussault; D A Fisher
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.